BX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BX is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants a clear entry today. The business has supportive long-term fundamentals and constructive institutional/catalyst news, but the current technical trend is still weak, options sentiment is bearish, and the stock is trading below key short-term levels. I would not buy aggressively at this moment; holding for a better setup is the better call.
The current price is 116.3, slightly above the previous close of 116.14, but the broader recent move remains weak after a -1.58% regular session decline. MACD histogram is -0.494 and negatively expanding, which confirms downside momentum. RSI_6 at 35.398 is weak but not yet deeply oversold. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, showing the trend is still under pressure. Price is below the pivot at 118.147 and only modestly above support at S1 113.846, with resistance at 122.449. Overall, the chart points to a weak short-term trend and no clear buy trigger.
News is supportive for the broader alternative asset and AI-financing ecosystem. Blackstone is involved in major debt financing tied to Anthropic, which highlights continued capital-markets activity and reinforces Blackstone’s role in large-scale private credit and financing. Analyst commentary also remains mostly positive on the long term: multiple firms kept Buy/Outperform ratings, and several noted strong fundraising, resilient institutional demand, and solid portfolio performance. Congress trading data is also mildly positive, with 2 purchase transactions versus 1 sale transaction over the last 90 days, suggesting favorable political sentiment.
Short-term price action is weak, the MACD is deteriorating, and moving averages remain bearish. Options data leans bearish with elevated put demand. Several analysts lowered price targets, mainly due to softer near-term management and performance fees, and some firms remain only Neutral. Hedge funds and insiders are both neutral with no significant trading trends. The stock also appears to have limited near-term momentum according to similar candlestick pattern analysis, with a negative one-month expectation.
Financial snapshot data was unavailable due to an error, so the latest quarter financials cannot be directly assessed from the provided numbers. However, analyst notes reference Q1 results: Blackstone reportedly beat on fundraising, deployments, and realizations, while near-term management fees were softer and EPS estimates were trimmed by several firms. The latest quarter season referenced is Q1 2026. Net takeaway: underlying business activity appears solid, but near-term earnings quality and fee growth look less strong.
Wall Street remains mixed but slightly positive overall. Several firms kept Buy/Outperform/Overweight ratings, including TD Cowen, RBC, Oppenheimer, Evercore ISI, Citizens, and Morgan Stanley, but price targets were generally lowered across the board, showing some caution on near-term earnings power. Piper Sandler and JPMorgan are Neutral, which adds to the mixed picture. Pros: strong fundraising, resilient portfolio performance, and long-term earnings power. Cons: softer management fees, lowered EPS estimates, and weaker current earnings quality. Overall, the pros view is constructive long term, but near-term sentiment is cautious.
